NCT06255795
- Conditions
- Extranodal Natural Killer T Cell Lymphoma
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Extranodal Natural Killer T Cell Lymphoma
Explore clinical trials studying Extranodal Natural Killer T Cell Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Extranodal Natural Killer T Cell Lymphoma trial results
Active, Not Recruiting
Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
NCT05464433
- Conditions
- Extranodal Natural Killer T Cell Lymphoma
- Locations
-
- Beijing Tongren Hospital, Capital Medical University Beijing, China
- Peking Union Medical College Hospital Beijing, China
- The Second Hospital of Dalian Medical University Dalian, China
- Sun Yat-Sen University Cancer Center Guangzhou, China